≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_VULVA_EXALLC for full statistics.

Carcinoma in situ of vulva

DOID Endpoint Browser

CD2_INSITU_VULVA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

  • not C3_VULVA
293065

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D07.1&
  • Hospital discharge: ICD-9 — 2333B
  • Cause of death: ICD-10 — D07.1&
  • Cause of death: ICD-9 — 2333B
  • Cancer registry: Topography ICD-O-3 — C51
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

266

4. Check minimum number of events

None

266

5. Include endpoints

None

266

6. Filter based on genotype QC (FinnGen only)

266

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ penis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 266 266 -
Unadjusted period prevalence (%) 0.09 0.09 -
Median age at first event (years) 58.75 58.75 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
239
Matched controls
2389
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
180.3
185.4
182
41
ULA02
NOMESCO Finland
Kolposcopy
87.9
164.7
209
175
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
1142.1
161.2
140
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
155.8
132
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
117.9
90.5
94
13
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
84.5
76
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
18.2
84.4
162
247
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
1123.0
83.8
77
*
LFC00
NOMESCO Finland
Partial excision of vulva
436.7
67.1
64
*
D06BB10
ATC
imiquimod; topical
17.1
45.3
75
62
LEB00
NOMESCO Finland
Biopsy of vagina
26.0
41.3
58
29
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
49.6
40.2
48
12
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
11.1
38.4
79
102
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
13.8
29.4
52
47
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
6.4
26.7
79
170
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
26.5
25
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.2
24.1
146
652
N90.0
ICD-10 Finland
Mild vulvar dysplasia
60.5
23.6
27
5
LDA10
NOMESCO Finland
Curettage of cervix uteri
10.1
23.3
48
58
D07AD01
ATC
clobetasol; topical
4.8
22.3
88
258
A63.0
ICD-10 Finland
Anogenital (venereal) warts
11.7
20.3
38
38
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
20.1
19
*
N90.4
ICD-10 Finland
Leukoplakia of vulva
54.2
17.3
20
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
8.0
16.8
39
57
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.3
15.4
50
114
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
14.7
14
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
11.1
14.4
27
27
N76.6
ICD-10 Finland
Ulceration of vulva
32.3
14.1
18
6
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
56.9
14.0
16
*
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
13.7
13
*
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
26.5
11.3
15
6
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
114.9
10.5
11
*
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
24.7
10.4
14
6
N87.1
ICD-10 Finland
Moderate cervical dysplasia
9.8
10.2
20
22
D06BB04
ATC
podophyllotoxin; topical
6.1
10.0
27
49
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
104.0
9.5
10
*
J02AC01
ATC
fluconazole; systemic
2.3
9.3
144
938
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
19.5
9.0
13
7
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.1
8.9
53
202
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
93.2
8.5
9
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.5
8.4
19
27
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
7.5
8.4
19
27
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
10.6
8.2
15
15
N89.0
ICD-10 Finland
Mild vaginal dysplasia
34.6
8.1
10
*
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
7.4
7.9
18
26
B01AB10
ATC
tinzaparin; parenteral
3.9
7.9
32
91
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
7.6
43
158
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
7.6
106
638
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
82.5
7.5
8
*
P01AB01
ATC
metronidazole; oral, rectal
2.1
7.3
128
842
WX320
NOMESCO Finland
Spinalanesthesy
2.3
7.2
75
392
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
41.3
6.8
8
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
6.7
96
577
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
71.7
6.5
7
*
J01DB01
ATC
cefalexin; oral
2.4
6.0
204
1702

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
91
41
33.22
129.94
3.6
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
38
16
27.54
53.95
3.2
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
71
111
8.36
46.07
2.9
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
162
578
5.61
43.44
2.7
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
216
1026
6.88
39.91
5.7
2.1
—
—
—
0
0
(4035726)
87
210
5.67
36.06
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
89
327
3.59
19.99
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
178
1113
2.81
14.17
4.5
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
107
569
2.47
11.20
2.2
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
125
743
2.29
9.86
2.6
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
88
457
2.38
9.44
3.0
2.3
e6/l
7.0
7.8
0.10
73
411
(3037467) Urinalysis macro (dipstick) panel - Urine
215
1627
2.68
9.43
6.0
4.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
54
226
2.74
9.06
1.8
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
64
298
2.51
8.64
1.9
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
80
433
2.21
7.56
3.0
2.6
mosm/kgh2o
499.2
514.9
0.25
69
374
(3002582) Erythrocytes [#/volume] in Urine
109
672
2.05
7.30
3.7
3.0
e6/l
21.2
49.0
1.31
94
508
(3023368) Bacteria identified in Blood by Culture
89
517
2.08
6.94
5.0
3.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
123
812
1.96
6.63
4.2
3.6
e6/l
30.0
88.2
2.51
97
547
(36304419) Bacteria [Presence] in Urine
98
606
1.98
6.33
3.9
2.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
137
951
1.91
6.25
6.2
3.6
g/l
35.5
36.0
0.53
128
886
(3030467) Casts [#/volume] in Urine by Automated count
99
620
1.95
6.13
3.8
2.8
e6/l
0.1
0.5
3.25
80
454
(3026008) Bacteria identified in Urine by Culture
121
815
1.89
5.98
2.9
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
167
1251
1.90
5.88
6.2
5.4
umol/l
9.5
9.7
0.19
158
1177
(3013650) Neutrophils [#/volume] in Blood by Automated count
177
1370
1.87
5.42
10.0
8.8
e9/l
4.1
3.9
0.44
161
1203
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
116
796
1.81
5.22
4.1
2.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
49
253
2.15
5.06
2.8
2.1
umol/l
4.9
6.6
0.96
42
223
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
93
602
1.84
5.03
3.0
2.9
ng/l
1037.7
896.4
0.16
79
512
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
33
144
2.47
5.02
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
76
462
1.90
4.99
1.7
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
154
1167
1.76
4.80
4.5
3.9
estimate
0.0
0.0
0.50
33
227
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
142
1052
1.75
4.79
5.9
4.8
mmol/l
1.2
1.2
0.29
124
948
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
215
1805
2.00
4.75
9.3
6.9
u/l
79.1
77.2
0.26
208
1682
(3009508) Creatinine [Moles/volume] in Urine
96
637
1.79
4.74
5.6
2.9
mmol/l
5.8
6.8
1.52
81
523
(40768443) Skin Pathology biopsy report
28
116
2.58
4.74
1.4
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
20
69
3.05
4.71
1.3
2.6
g/l
2.2
1.6
1.00
15
59
(3032080) INR in Blood by Coagulation assay
121
860
1.75
4.70
16.5
7.1
inr
1.3
1.1
1.08
31
270
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
104
712
1.76
4.58
3.6
2.1
u/l
56.2
56.6
0.05
97
649
(3021601) Nitrite [Presence] in Urine by Test strip
152
1159
1.73
4.53
5.5
5.2
estimate
0.0
0.0
0.00
32
226
(42870588) Differential panel, method unspecified - Blood
106
732
1.74
4.52
8.1
5.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
152
1166
1.71
4.37
6.7
5.6
mmol/l
1.2
1.2
0.77
124
978
(3012516) Albumin [Mass/volume] in Urine
90
599
1.76
4.33
4.6
3.0
mg/l
106.0
142.2
0.11
63
341
(3020564) Creatinine [Moles/volume] in Serum or Plasma
259
2415
3.75
4.12
22.0
14.7
umol/l
72.2
68.6
0.87
259
2415
(3006315) Basophils [#/volume] in Blood
150
1158
1.68
4.12
7.6
5.3
e9/l
0.0
0.0
0.40
137
1000
(3001604) Monocytes [#/volume] in Blood
149
1150
1.67
4.08
7.6
5.3
e9/l
0.6
0.5
0.39
137
996
(3013115) Eosinophils [#/volume] in Blood
153
1197
1.65
3.91
7.7
5.7
e9/l
0.2
0.2
0.67
142
1057
(3013826) Glucose [Moles/volume] in Serum or Plasma
162
1289
1.66
3.85
4.8
4.0
mmol/l
6.6
6.4
0.43
154
1186
(3018418) pH of Serum or Plasma
103
737
1.65
3.69
4.9
3.5
ph
7.4
7.4
0.52
19
139
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
55
331
1.83
3.65
2.1
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
42
231
1.97
3.65
1.8
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
150
1182
1.62
3.61
7.7
5.3
e9/l
1.9
1.9
0.12
139
1045
(3002030) Lymphocytes/100 leukocytes in Blood
143
1115
1.61
3.59
8.0
5.5
%
27.6
29.2
0.97
137
1031
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
46
3.16
3.58
1.1
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
91
637
1.65
3.53
5.4
3.8
mg/mmol
18.9
4.7
0.99
58
355
(3009343) pH of Capillary blood
24
107
2.37
3.50
5.0
3.2
ph
7.4
7.4
—
6
14
(3011397) Hemoglobin [Presence] in Urine by Test strip
77
517
1.69
3.49
3.9
3.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
141
1102
1.59
3.46
7.5
5.3
%
58.3
56.3
1.18
134
1022
(3019069) Monocytes/100 leukocytes in Blood
140
1093
1.59
3.45
8.2
5.6
%
8.3
8.4
0.24
134
1014
(3044889) 12 lead EKG panel
191
1610
1.66
3.40
4.5
3.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
135
1050
1.58
3.34
8.1
5.4
%
0.6
0.7
0.75
128
965
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
19
4.86
3.26
1.0
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
138
1088
1.56
3.16
8.0
5.3
%
2.9
2.8
0.12
132
1001
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
7
12
5.96
3.04
1.0
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
240
2183
2.02
2.98
17.7
11.7
ml/min/173m2
80.9
81.3
0.11
224
1781
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
217
1916
1.72
2.97
5.4
4.5
pmol/l
14.8
14.7
0.30
199
1752
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
250
2310
2.37
2.95
20.9
12.5
mg/l
22.9
19.7
0.79
213
1792
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
360
1.70
2.95
3.2
2.6
e6/l
1.2
1.1
0.11
40
186
(3026389) Candida sp identified in Specimen by Organism specific culture
10
30
3.42
2.93
1.0
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
203
1.89
2.91
4.6
6.2
mmol/l
0.1
1.5
1.18
24
170
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
121
940
1.53
2.89
2.0
1.9
pmol/l
103.1
99.2
0.24
52
443
(3051651) Icteric interference index of Serum or Plasma
7
13
5.50
2.88
1.7
2.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
41
243
1.81
2.85
28.1
17.5
inr
1.3
1.3
—
7
40
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
61
405
1.66
2.84
3.9
3.8
ng/l
122.5
169.7
0.20
39
298
(3015736) pH of Urine
115
886
1.52
2.84
3.6
3.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
36
3.14
2.84
11.6
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
44
268
1.77
2.79
2.3
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
85
2.33
2.77
1.9
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
141
1141
1.50
2.72
4.4
3.8
estimate
0.0
0.0
0.00
31
233
(3045414) Leukocytes [Presence] in Urine
22
106
2.17
2.72
1.6
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
76
539
1.57
2.70
1.5
1.8
mg/l
0.8
0.9
0.35
58
408
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
29
156
1.96
2.69
2.3
3.1
ng/l
209.5
217.1
0.03
24
143
(40761511) CBC panel - Blood by Automated count
255
2389
2.63
2.68
19.5
11.7
—
—
—
0
0
(3019225) pH of Specimen
38
225
1.80
2.65
3.4
4.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
234
1.78
2.60
2.1
1.4
%
1.3
1.3
0.19
34
205
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
56
2.58
2.57
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
7
7.25
2.56
2.2
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
63
2.46
2.51
1.5
2.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
238
2184
1.85
2.50
4.3
3.9
mmol/l
1.3
1.2
0.86
218
2005
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
16
4.46
2.49
1.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
16
4.46
2.49
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
29
161
1.90
2.47
3.8
2.8
e9/l
4.7
4.0
0.80
19
130
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
286
1.69
2.46
4.0
4.3
%
33.4
33.3
0.02
29
182
(3019309) Folate [Moles/volume] in Red Blood Cells
59
403
1.60
2.44
1.6
1.7
nmol/l
1148.3
1162.5
0.04
45
293
(3004616) Nuclear Ab [Presence] in Serum
10
34
3.02
2.44
1.5
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
27
3.41
2.41
1.8
2.4
u/ml
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
12
5.09
2.41
1.8
2.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
28
155
1.90
2.41
2.0
2.6
e9/l
61.8
72.2
1.17
23
118
(3011288) Drugs identified in Urine by Screen method
11
40
2.83
2.40
3.8
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
201
1775
1.54
2.38
6.0
4.2
mm/h
13.9
11.8
1.21
188
1630
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
17
4.20
2.37
1.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
17
4.20
2.37
1.9
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
66
2.35
2.29
2.9
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
18
3.96
2.26
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
233
2139
1.72
2.25
6.4
5.5
mmol/mol
39.1
39.1
0.02
220
1996
(3021960) Folate [Moles/volume] in Serum or Plasma
74
542
1.51
2.24
1.3
1.5
nmol/l
25.3
22.5
0.60
63
451
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
80
2.20
2.24
1.8
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
36
2.85
2.22
8.5
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
96
743
1.46
2.20
4.4
2.7
u/l
30.8
29.2
0.34
89
710
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
176
1524
1.46
2.20
4.0
2.9
u/l
54.9
41.4
1.07
168
1420
(40758558) Short blood count panel - Blood
82
616
1.48
2.19
6.7
7.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
19
3.75
2.16
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
35
216
1.71
2.14
2.9
2.7
%
1.7
1.8
0.21
30
199
(3000494) Fungus identified in Specimen by Culture
44
289
1.63
2.13
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
62
2.33
2.11
6.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
69
2.24
2.09
6.1
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
10
5.07
2.08
1.6
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
10
5.07
2.08
1.0
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
111
1.97
2.07
6.6
4.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
76
2.18
2.07
5.3
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
81
614
1.46
2.05
4.8
4.2
estimate
0.0
0.0
0.00
33
233
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
211
1.70
2.04
1.7
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
38
2.70
2.03
1.2
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
127
1047
1.41
2.02
2.2
2.3
nmol/l
85.2
78.5
1.59
110
935
(3028300) Cannabinoids [Presence] in Urine
15
70
2.21
2.02
6.1
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
32
2.87
2.02
4.9
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
226
2073
1.60
2.01
18.2
13.6
%
38.1
39.5
1.16
161
1539
(3015377) Calcium [Moles/volume] in Serum or Plasma
104
829
1.42
2.00
4.1
3.2
mmol/l
2.4
2.4
0.46
90
729
(3000093) Morphology [Interpretation] in Blood Narrative
5
11
4.61
1.95
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
152
1.79
1.91
4.3
2.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
24
137
1.83
1.91
7.3
5.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
52
2.37
1.90
1.8
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
535
1.45
1.84
2.8
2.1
mg/l
3.5
3.1
0.44
55
454
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
240
2245
1.71
1.84
5.6
4.4
mmol/l
5.9
5.8
0.35
222
2060
(3006462) Nitrate [Presence] in Urine
5
12
4.22
1.83
4.4
5.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
109
1.90
1.83
12.8
4.8
mmol/l
25.5
25.3
0.07
20
109
(3013512) EKG study
85
663
1.41
1.82
3.5
3.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
246
2318
1.81
1.81
5.6
4.9
mmol/l
2.7
2.8
2.02
225
2142
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
74
2.09
1.79
3.5
2.0
u/l
2213.9
140.6
—
6
25
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
148
1.76
1.78
2.1
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
69
521
1.44
1.76
1.6
1.6
g/l
2.1
2.3
0.45
36
310
(40768441) Liver Pathology biopsy report
6
18
3.38
1.75
1.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
46
322
1.52
1.71
2.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
55
2.24
1.70
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
42
2.43
1.70
1.5
2.5
u/ml
0.3
0.4
—
5
24
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
247
1.58
1.69
2.3
1.8
—
—
—
0
0
(3000492) Spirometry study
31
198
1.64
1.69
1.4
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
39
264
1.56
1.68
4.0
2.1
%
23.5
21.9
0.34
33
224
(3000764) Benzodiazepines [Presence] in Urine
14
69
2.09
1.68
6.6
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
40
273
1.55
1.67
1.3
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
28
176
1.66
1.62
4.8
6.3
%
93.8
95.8
0.51
28
171
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
14
3.62
1.62
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
44
309
1.51
1.61
3.7
2.1
umol/l
12.8
13.6
0.29
38
285
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
114
1.82
1.61
1.8
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
137
1.74
1.61
1.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
32
2.55
1.61
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
43
301
1.51
1.60
2.0
2.0
ug/g
374.0
113.4
0.54
25
231
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
116
1.78
1.53
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
179
1.63
1.53
3.5
3.4
—
—
—
0
0
(4211845)
5
15
3.38
1.53
4.4
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
340
1.46
1.50
3.5
2.8
e6/l
3.4
3.8
0.12
32
166
(3021589) Normoblasts [#/volume] in Blood
122
1035
1.33
1.50
12.6
8.8
e9/l
0.0
0.0
0.27
104
851
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
359
1.45
1.47
2.5
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
52
2.16
1.46
7.7
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
52
2.16
1.46
1.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
59
2.08
1.46
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
16
3.16
1.44
2.0
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
16
3.16
1.44
2.8
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
22
2.77
1.44
3.0
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
100
828
1.33
1.44
3.8
3.5
ng/l
20.3
26.2
0.41
64
546
(3002032) Base excess in Venous blood by calculation
26
166
1.63
1.44
4.9
2.7
mmol/l
1.7
2.7
0.87
21
142
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
242
1.51
1.39
2.8
2.1
u/l
28.2
27.8
0.05
27
201
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
236
2227
1.53
1.39
6.5
5.3
mu/l
1.7
2.4
0.72
220
2048
(3026493) Urate [Moles/volume] in Serum or Plasma
69
543
1.37
1.38
2.8
2.5
umol/l
16143.3
7899.4
0.31
63
471
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
17
2.98
1.36
2.4
2.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
47
2.17
1.35
1.2
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
42
2.18
1.35
2.4
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
24
2.53
1.31
1.0
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
24
2.53
1.31
2.2
2.0
—
17.4
—
0
8
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
69
1.93
1.31
1.2
1.3
ug/g
379.1
290.4
—
7
37
(3013290) Carbon dioxide [Partial pressure] in Blood
9
44
2.08
1.28
23.3
2.6
kpa
5.2
5.0
—
9
44
(3027315) Oxygen [Partial pressure] in Blood
9
44
2.08
1.28
23.3
2.6
kpa
8.7
8.9
—
9
44
(3027944) Amphetamines [Presence] in Urine
13
70
1.90
1.26
7.1
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
49
2.08
1.23
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
275
1.45
1.22
10.1
6.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
19
2.66
1.22
1.0
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
19
2.66
1.22
1.8
1.4
ug/l
14.8
23.0
—
5
19
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
86
1.79
1.21
3.2
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
58
454
1.35
1.20
1.8
1.7
pmol/l
436.9
17251136.6
0.50
48
371
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
50
2.04
1.18
5.7
3.3
%
54.9
58.8
—
10
50
(3010421) pH of Blood
10
50
2.04
1.18
21.5
2.5
ph
7.4
7.4
—
10
44
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
50
2.04
1.18
5.4
2.8
e9/l
3.1
4.6
—
10
50
(3003694) ABO and Rh group [Type] in Blood
76
622
1.31
1.16
1.5
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
17
103
1.69
1.16
5.9
7.1
%
91.9
94.3
0.98
17
103
(44790049)
5
20
2.53
1.15
2.0
1.8
—
—
—
0
0
(44790048)
5
20
2.53
1.15
2.0
1.8
—
—
—
0
0
(44790047)
5
20
2.53
1.15
2.0
1.8
—
—
—
0
0
(44806118)
5
20
2.53
1.15
2.0
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
122
1063
1.27
1.15
3.1
2.7
ug/l
106.4
82.8
0.81
107
980
(3017181) Myelocytes/100 leukocytes in Blood
27
186
1.50
1.11
3.0
4.2
%
0.7
1.1
0.39
13
49
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
31
2.29
1.11
1.7
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
229
1.45
1.10
2.3
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
21
2.41
1.09
1.0
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
90
1.71
1.06
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
33
2.15
1.06
1.7
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
238
2273
1.45
1.05
4.9
4.3
mmol/l
1.6
1.6
0.73
220
2104
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
55
437
1.33
1.03
3.8
2.5
mmol/l
2.5
2.5
0.33
48
389
(3008898) HLA-B27 [Presence]
5
109
0.45
1.03
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
239
2286
1.45
1.03
5.1
4.4
mmol/l
4.7
4.9
1.39
222
2127
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
91
1.69
1.03
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
224
1.43
1.02
3.8
3.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
35
2.03
1.00
1.9
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
35
2.03
1.00
1.3
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
199
1.45
1.00
5.4
3.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
92
1.67
0.99
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
200
1.45
0.98
1.7
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
50
1.83
0.97
1.6
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
227
1.41
0.96
2.2
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
51
1.79
0.95
1.7
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
51
1.79
0.95
1.3
6.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
86
1.66
0.93
1.4
1.5
miu/ml
391.3
268.6
—
6
48
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
28
2.17
0.92
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
161
1475
1.23
0.90
3.3
3.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
64
1.75
0.87
1.4
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
30
2.02
0.87
1.5
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
30
2.02
0.87
1.8
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.02
0.87
1.0
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
45
1.80
0.85
1.8
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
31
1.96
0.85
1.2
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
57
1.78
0.85
3.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
46
1.76
0.83
2.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
46
1.76
0.83
2.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
148
1.45
0.80
1.2
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
3.0
—
40.4
—
0
7
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
59
1.72
0.77
2.0
1.7
ug/l
172.3
159.9
—
10
52
(3025159) Blasts/100 leukocytes in Blood
23
167
1.41
0.76
3.3
4.4
%
0.0
0.0
—
10
36
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
101
894
1.21
0.76
4.7
3.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
24
2.10
0.75
4.8
2.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
177
1.39
0.74
3.3
4.3
%
0.0
0.1
1.90
12
44
(3023511) Choriogonadotropin [Units/volume] in Urine
9
56
1.63
0.73
2.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.0
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
25
2.02
0.73
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
25
2.02
0.73
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
2.0
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
26
1.94
0.71
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
58
1.57
0.70
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
58
1.57
0.70
2.0
1.9
—
—
—
0
0
(3020891) Body temperature
11
69
1.62
0.69
12.5
4.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
69
1.62
0.69
1.2
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
63
541
1.22
0.64
5.1
4.5
—
—
—
0
0
(4268621)
5
29
1.74
0.64
2.0
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
29
1.74
0.64
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
29
1.74
0.64
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
104
1.47
0.64
1.2
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.8
—
257.0
—
0
21
(3037522) Nuclear Ab [Titer] in Serum
42
348
1.25
0.60
1.6
1.4
titre
800.0
651.9
0.15
14
81
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
89
1.48
0.59
6.7
7.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
22
168
1.34
0.57
3.3
4.3
%
0.0
0.5
—
9
32
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
36
1.68
0.57
1.2
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
65
1.56
0.56
1.0
1.3
—
—
—
0
0
(4281824)
6
37
1.64
0.56
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
57
492
1.20
0.56
5.3
4.1
kg/l
1.0
1.0
—
9
69
(4094501)
9
60
1.52
0.55
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
38
1.59
0.54
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
134
1.37
0.54
1.1
1.0
—
—
—
0
0
(4034850)
9
61
1.49
0.54
16.9
8.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
91
1.45
0.54
1.5
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
40
1.51
0.52
2.5
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
75
1.49
0.51
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
211
0.74
0.49
1.4
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
47
1.50
0.48
6.3
2.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
81
0.61
0.46
3.6
3.3
u/ml
19.0
28.2
—
5
81
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
69
1.47
0.45
2.2
2.1
%
100.8
99.4
—
10
62
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
8
57
1.42
0.42
2.0
1.6
—
0.4
—
0
5
(3037121) Protein [Mass/volume] in Urine
10
70
1.45
0.42
1.4
3.1
g/l
0.1
0.1
—
5
18
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
114
1.33
0.41
1.3
1.3
—
—
—
0
0
(4010399)
21
168
1.27
0.41
1.7
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
6.8
—
0
5
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
12
88
1.38
0.40
5.8
1.4
g/l
1.3
1.2
0.46
12
83
(3025941) Bacteria identified in Stool by Culture
18
142
1.29
0.39
1.6
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
35
1.44
0.39
2.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
35
1.44
0.39
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
197
1.24
0.39
2.0
2.7
ml/min/173m2
53.9
67.6
—
7
78
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
36
1.40
0.38
2.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
71
1.28
0.36
1.4
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
45
1.34
0.34
1.7
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
201
1.21
0.34
7.2
3.8
mmol/l
1.2
1.2
0.71
19
174
(3001019) Free T4 and TSH panel - Serum or Plasma
18
148
1.23
0.30
2.0
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
12
150
0.79
0.27
1.3
1.2
u/ml
70.6
184.3
1.54
12
139
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
64
590
1.11
0.27
1.4
1.2
u/ml
0.8
1.6
—
8
163
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
139
0.78
0.27
1.1
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
14
113
1.25
0.27
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
66
1.22
0.27
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
199
1.17
0.24
1.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
152
1.20
0.24
1.3
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
38
1.32
0.23
1.4
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
479
0.90
0.22
1.4
1.3
u/ml
2.5
10.5
2.33
15
189
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
9.1
—
0
11
(3011648) Oxygen content in Venous blood
0
12
0.00
0.21
0.0
1.7
—
11.9
—
0
12
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
0.1
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
117
1.21
0.21
1.2
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
49
1.23
0.20
1.7
1.1
mmol/l
3.9
3.8
—
6
43
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
483
1.10
0.20
1.4
1.3
iu/ml
23.3
33.4
0.44
12
163
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
72
679
1.08
0.20
1.9
1.6
mmol/l
1.5
1.4
0.74
63
571
(3005033) Fetal Nuchal fold Thickness US
6
50
1.20
0.20
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
50
1.20
0.20
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
53
1.14
0.19
1.7
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
39
359
1.10
0.18
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
205
1.13
0.17
1.0
1.2
iu/ml
123.9
145.0
—
5
90
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
19
167
1.15
0.17
1.5
1.3
—
47.1
—
0
9
(1002224) Polysomnography panel
12
102
1.18
0.15
1.2
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
78
815
0.94
0.15
2.9
2.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
202
0.88
0.15
1.7
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
83
1.09
0.15
1.8
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
93
1.19
0.14
6.5
2.5
mmol/l
24.0
25.7
1.09
11
93
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
23
208
1.12
0.14
2.0
3.0
u/ml
72.7
61.6
0.08
23
199
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
107
0.84
0.13
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
662
1.06
0.12
4.1
3.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
86
1.17
0.11
1.4
2.3
g/l
2.7
3.1
—
5
72
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
44
1.14
0.10
1.6
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
87
1.16
0.09
1.4
2.3
g/l
6.9
9.9
—
5
77
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
64
1.10
0.08
1.7
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
68
1.03
0.08
1.1
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
95
0.84
0.07
4.4
2.0
%
1.5
1.1
—
8
95
(3003338) MCHC [Mass/volume]
196
1942
1.04
0.06
23.9
16.6
g/l
330.7
330.6
0.10
196
1932
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
91
1.10
0.04
1.4
2.3
g/l
8.0
7.6
—
5
74
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
91
1.10
0.04
1.4
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
91
1.10
0.04
1.4
2.3
g/l
3.7
3.7
—
5
72
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
132
0.98
0.00
2.5
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
116
1.04
0.00
1.8
3.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
185
0.97
0.00
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
255
0.98
0.00
1.8
1.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
31.1
—
0
9
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
90
1.00
0.00
8.1
3.3
%
50.9
46.4
—
9
90
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.8
—
116.4
—
0
8
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
66
0.91
0.00
1.7
1.2
—
42.6
—
0
7
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.5
—
0
6
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
93.0
—
0
7
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
60
1.00
0.00
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
60
1.00
0.00
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
133.9
—
0
8
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
63
0.95
0.00
2.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
60
1.00
0.00
1.3
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
60
1.00
0.00
1.3
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_VULVA – Carcinoma in situ of vulva

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).